Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.
暂无分享,去创建一个
[1] R. Perng,et al. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[2] F. Salazar-Onfray. Interleukin-10: a cytokine used by tumors to escape immunosurveillance , 1999, Medical oncology.
[3] R. Coffman,et al. The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo. , 1998, International immunology.
[4] W. Tsai,et al. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. , 1997, Chest.
[5] J. Whang‐Peng,et al. Restoration of the Immunocompetence by IL‐2 Activation and TCR‐CD3 Engagement of the In Vivo Anergized Tumor‐Specific CTL from Lung Cancer Patients , 1997, Journal of immunotherapy.
[6] A. Mackensen,et al. Immunostimulatory cytokines in somatic cells and gene therapy of cancer. , 1997, Cytokine & growth factor reviews.
[7] J. Whang‐Peng,et al. Elevation of interleukin-10 levels in malignant pleural effusion. , 1996, Chest.
[8] E. Maxwell,et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism , 1996, The Journal of experimental medicine.
[9] M. Gore,et al. IL‐12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL) , 1996, Clinical and experimental immunology.
[10] G. Trinchieri,et al. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.
[11] S. Sone,et al. Interleukin‐10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages , 1994, Journal of leukocyte biology.
[12] S. Rosenberg,et al. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy , 1991, The Journal of experimental medicine.
[13] M. Alderson,et al. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood , 1990, The Journal of experimental medicine.
[14] E. Reinherz,et al. Monoclonal antibodies defining distinctive human T cell surface antigens. , 1979, Science.
[15] H. Yamaue,et al. The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor , 1992, Biotherapy.